This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Both sides next revision |
resources:fluoroquinolones [2019/12/25 00:40]
bpaddock Added ruptures or tears in the aorta blood vessel FDA warning. | resources:fluoroquinolones [2020/07/14 14:19] (current)
bpaddock Fluoroquinolones are a potent form of chemotherapy |
|---|
| FDA Hearing [[http://www.fda.gov/AdvisoryCommittees/Calendar/ucm465275.htm|meeting brief]] and the [[https://web.archive.org/web/20170113234645/http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM467383.pdf|617 page PDF; (Note the FDA removed this document from their website. Fill in your own Conspiricy Theory)]] report where the the FDA identified a syndrome associated with fluoroquinolone toxicity—one that “floxies” have been pushing for recognition of for years. It is called Fluoroquinolone Associated Disability (FQAD). | FDA Hearing [[http://www.fda.gov/AdvisoryCommittees/Calendar/ucm465275.htm|meeting brief]] and the [[https://web.archive.org/web/20170113234645/http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM467383.pdf|617 page PDF; (Note the FDA removed this document from their website. Fill in your own Conspiricy Theory)]] report where the the FDA identified a syndrome associated with fluoroquinolone toxicity—one that “floxies” have been pushing for recognition of for years. It is called Fluoroquinolone Associated Disability (FQAD). |
| </WRAP> | </WRAP> |
| | ---- |
| | |
| | ====== Fluoroquinolones are a potent form of chemotherapy ====== |
| | |
| | Katrina L Schmid PhD BAppSc (Optom) (Hons) GradCertEd (Higher Ed) GradCertOcThera SFHEA |
| | |
| | Version of Record online:02 June 2020 |
| | |
| | https://doi.org/10.1111/cxo.13102 |
| | |
| ---- | ---- |
| |